Felice S. Pasini

Peschiera Del Garda, IT 
Peschiera Del Garda, IT 

Overview

Felice Pasini practices practicing medicine in Peschiera Del Garda, Italy.

Her clinical expertise encompasses Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, and Nephrectomy.

She is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Peschiera Del Garda, Italy
Other Locations
Rovigo, Italy
Verona, Italy
Genoa, Italy
Camposampiero, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer
Enrollment Status: Terminated
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drug: Trilaciclib
Study Phase: Phase 3
Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial
Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial
Enrollment Status: Completed
Publish Date: April 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

36 Total Publications

Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit.
Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 18, 2021

Frequently Asked Questions about Felice S. Pasini

Is Felice S. Pasini a top-rated expert for Chromophobe Renal Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Felice S. Pasini is classified as an Experienced expert for Chromophobe Renal Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Felice S. Pasini participate in research or clinical trials?

Yes. Felice S. Pasini has published 36 articles and abstracts on conditions like Chromophobe Renal Cell Carcinoma. You can view a list of Felice S. Pasini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pasini's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile